N-hexacosanol ameliorates streptozotocin-induced diabetic rat nephropathy

European Journal of Pharmacology

Volumn 544, Issue 1-3, 2006, Pages 132-137

  Saito, Motoaki ^a   Kinoshita, Yukako ^a   Satoh, Itaru ^a   Shinbori, Chiko ^a   Kono, Tomoharu ^a   Hanada, Takuya ^a   Uemasu, Jiro ^b   Suzuki, Hiroto ^c   Yamada, Masashi ^c   Satoh, Keisuke ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b Uemasu Clinic   (Japan)

^c MEIJI DAIRIES CORPORATION   (Japan)

Author keywords

Diabetes; Malonaldehyde; N hexacosanol; Nephropathy; PKC (protein kinase C); TGF 1 (transforming growth factor beta 1)

Indexed keywords

CREATININE; HEXACOSANOL; MALONALDEHYDE; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DRUG EFFECT; HISTOLOGY; INTERSTITIAL NEPHRITIS; KIDNEY MASS; MALE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; RAT STRAIN; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD UREA NITROGEN; CREATININE; DIABETIC NEPHROPATHIES; FATTY ALCOHOLS; INSULIN; MALE; MALONDIALDEHYDE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33746619146     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.06.001     Document Type: Article

References (25)

1. Azzouz M., Kennel P.F., Warter J.-.M., Poindron P., and Borg J. Enhancement of mouse sciatic regeneration by the long chain fatty alcohol, N-hexacosanol. Exp. Neurol. 138 (1996) 189-197
2. Bostsoglou N.A. Rapid, sensitive, and specific thiobarbituric acid method for measuring lipid peroxidation in animal tissue, food and feedstuff samples. J. Agric. Food Chem. 42 (1994) 1931-1937
3. Brunner A.M., Marquardt H., Malacko A.R., Lioubin M.N., and Purchio A.F. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor beta 1 precursor. Expression and characterization of mutant proteins. J. Biol. Chem. 264 (1989) 13660-13664
4. Chen S., Jim B., and Ziyadeh F.N. Diabetic nephropathy and transforming growth factor-β: transforming our view of glomerulosclerosis and fibrosis build-up. Semin. Nephrol. 23 (2003) 532-543
5. Cooper M.E., Cao Z., Rumble J.R., Jandeleit K., Allen T.J., and Gilbert R.E. Attenuation of diabetes-associated mesenteric vascular hypertrophy with perindopril: morphological and molecular biological studies. Metabolism 47 suppl 1 (1998) 24-27
6. Craven P.A., Davidson C.M., and DeRubertis F.R. Increase in diacyglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39 (1990) 667-674
7. Damge C., Hillaire-Buys D., Koenig M., Gross R., Hoeltzel A., Chapal J., Balboni G., Borg J., and Ribes G. Effect of N-hexacosanol on insulin secretion in the rat. Eur. J. Pharmacol. 274 (1995) 133-139
8. The Diabetic Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Eng. J. Med. 329 (1993) 977-986
9. Gonzalez de Aguilar J.-L., Girlanda-Junges C., Coowar D., Duportail G., Loeffler J.-P., and Luu B. Neurotrophic activity of 2,4,4-trimethyl-3-(15-hydroxypentadecyl)-2-cyclohexen 1-one in cultured central nervous system neurons. Brain Res. 920 (2001) 65-73
10. Holck P., and Rasch R. Structure and segmental localization of glycogen in the diabetic rat kidney. Diabetes 42 (1993) 891-900
11. Kashiba M., Oka J., Ichikawa R., Kasahara E., Inayama T., Kageyama A., Kageyama H., Osaka T., Umegaki K., Matsumoto A., Ishikawa T., Nishikimi M., Inoue M., and Inoue S. Impaired ascorbic acid metabolism in streptozotocin-induced diabetic rats. Free Radic. Biol. Med. 33 (2002) 1221-1230
12. Kinoshita Y., Saito M., Satoh I., Shomori K., Suzuki H., Yamada M., Kono T., and Satoh K. General administration of cyclohexenonic long-chain fatty alcohol ameliorates hyperreactivity of STZ-induced diabetic rat aorta. Life Sci. 78 (2006) 1508-1514
13. Lee B.-H., Yu M.-R., Yang Y., Jiang Z., and Ha H. Reactive oxygen species-regulated signal pathways in diabetic nephropathy. J. Am. Soc. Nephrol. 14 (2003) S241-S245
14. Luu B., de Aguilar J.L.G., and Girlanda-Junges C. Cyclohexenonic long-chain fatty alcohol as neuronal growth stimulators. Molecules 5 (2000) 1439-1460
15. Masmoudi, A., Labourdette, G., Mersel, M., Huang, F.L., Huang, K.P., Vincendon, G., Malviya, A.N., 1994. Protein kinase C located in rat liver nuclei. Partial purification and biochemical and immunochemical characterization. J. Biol. Chem. 264, 1172-1179.
16. Metz T.O., Alderson N.L., Thorpe S.R., and Baynes J.W. Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications. Arch. Biochem. Biophys. 419 (2003) 41-49
17. Oates P.J., and Mylari B.L. Aldose reductase inhibitors: therapeutic implications for diabetic complications. Expert Opin. Investig. Drugs 8 (1999) 2095-2119
18. Rasch R. Tubular lesions in streptozotocin-diabetic rats. Diabetologia 27 (1984) 32-37
19. Saito M., Suzuki H., Yamada M., and Miyagawa I. Preventive effect of long-chain fatty alcohol on ischemia-reperfusion injury in the rat bladder. Eur. J. Pharmacol. 454 (2002) 81-84
20. Satoh I., Saito M., Kinoshita Y., Shomori K., Suzuki H., Yamada M., Kono T., and Satoh K. Effects of cyclohexenonic long-chain fatty alcohol on diabetic rat trachea. Life Sci. 77 (2005) 2030-2039
21. Suzuki H., Saito M., Kinoshita Y., Satoh I., Kono T., Shinbori C., Anastasios S., Yamada M., and Satoh K. Preventive effect of cyclohexenonic long-chain fatty alcohol on diabetic neuropathy in the rat bladder. Can. J. Physiol. Pharmacol. 84 (2006) 195-201
22. Sharma K., and Ziyadeh F.N. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin. Nephrol. 17 (1997) 80-92
23. Watanabe T., and Miyagawa I. Effects of long-chain fatty alcohol on peripheral nerve conduction and bladder function in diabetic rats. Life Sci. 70 (2002) 2215-2224
24. Watanabe N., Kamei S., Ohkubo A., Yamanaka M., Ohsawa S., Makino K., and Tokuda K. Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer. Clin. Chem. 32 (1986) 1551-1554
25. Yamagishi S.-H., Inagaki Y., Okamoto T., Amano S., Koga K., and Takeuchi M. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-β overexpression in proximal tubular cells. Kidney Int. 63 (2003) 464-473